Cutting Edge Research that Translates into Patient Care
In addition, our research program has an unparalleled history of introducing new forms of treatment for the patients affected by malignant brain tumors. For example, the only two new effective surgical treatments for malignant brain tumors approved by FDA (Gliadel and GliaSite) were discovered and developed right here at Johns Hopkins. Our national leading role in the design and the completion of multi-center clinical trials allows us to apply the most promising discoveries from the laboratory to patient care in an effective and expeditious fashion. Presently, our most exciting areas of research include immunotherapy of brain tumors, adult stem cells and local delivery of a variety of new drug treatment options for brain tumors.
Follow the links below to learn more about ongoing research at the Johns Hopkins Comprehensive Brain Tumor Center:
- Immune Response to Brain Tumors
- Local Drug Delivery to Brain Tumors
- New Drug Targets for Brain Cancers
- Stem Cells and Brain Tumors
Learn more about ongoing studies in our research laboratories.